Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 5, 2020
Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus InfectionEli Zuckerman, Julio A Gutierrez, Douglas E Dylla, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 30, 2020
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1Ted R Mikuls, Sindhu R Johnson, Liana Fraenkel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 10, 2020
Fenebrutinib versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double-Blind, Phase II Trial (ANDES Study)Stanley Cohen, Katie Tuckwell, Tamiko R Katsumoto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 5, 2020
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3Ted R Mikuls, Sindhu R Johnson, Liana Fraenkel, et al.
Rheumatology and Therapy|June 20, 2021
A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational StudyStanley Cohen, Alvin F Wells, Jeffrey R Curtis, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 1, 2020
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 2Ted R Mikuls, Sindhu R Johnson, Liana Fraenkel, et al.
Annals of the Rheumatic Diseases|August 8, 2020
Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world dataPhilip Mease, Christina Charles-Schoeman, Stanley Cohen, et al.
Arthritis and Rheumatism|January 26, 2013
Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic studyDésirée van der Heijde, Yoshiya Tanaka, Roy Fleischmann, et al.
Inflammatory Bowel Diseases|July 6, 2010
ImproveCareNow: The development of a pediatric inflammatory bowel disease improvement networkWallace Crandall, Michael D Kappelman, Richard B Colletti, et al.
Gastroenterology|October 29, 2013
Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's diseaseThomas D Walters, Mi-Ok Kim, Lee A Denson, et al.
Pageof 11